Cargando…

Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening

We aimed to determine participation in low‐dose computed tomography (LDCT) of individuals with a family history of common cancers in a population‐based screening program to provide timely evidence in high‐risk populations in China. The analysis was conducted using data from the Cancer Screening Prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lan‐Wei, Meng, Qing‐Cheng, Zheng, Li‐Yang, Chen, Qiong, Liu, Yin, Xu, Hui‐Fang, Kang, Rui‐Hua, Zhang, Lu‐Yao, Liu, Shu‐Zheng, Sun, Xi‐Bin, Zhang, Shao‐Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790604/
https://www.ncbi.nlm.nih.gov/pubmed/35362560
http://dx.doi.org/10.1002/ijc.34010
_version_ 1784859216242016256
author Guo, Lan‐Wei
Meng, Qing‐Cheng
Zheng, Li‐Yang
Chen, Qiong
Liu, Yin
Xu, Hui‐Fang
Kang, Rui‐Hua
Zhang, Lu‐Yao
Liu, Shu‐Zheng
Sun, Xi‐Bin
Zhang, Shao‐Kai
author_facet Guo, Lan‐Wei
Meng, Qing‐Cheng
Zheng, Li‐Yang
Chen, Qiong
Liu, Yin
Xu, Hui‐Fang
Kang, Rui‐Hua
Zhang, Lu‐Yao
Liu, Shu‐Zheng
Sun, Xi‐Bin
Zhang, Shao‐Kai
author_sort Guo, Lan‐Wei
collection PubMed
description We aimed to determine participation in low‐dose computed tomography (LDCT) of individuals with a family history of common cancers in a population‐based screening program to provide timely evidence in high‐risk populations in China. The analysis was conducted using data from the Cancer Screening Program in Urban China (CanSPUC), which recruited 282 377 participants aged 40 to 74 years from eight cities in the Henan province. Using the CanSPUC risk score system, 55 428 participants were evaluated to have high risk for lung cancer and were recommended for LDCT. We calculated the overall and group‐specific participation rates using family history of common cancers and compared differences in participation rates between different groups. Odds ratios (ORs) and 95% confidence intervals were derived by multivariable logistic regression. Of the 55 428 participants, 22 260 underwent LDCT (participation rate, 40.16%). Family history of lung, esophageal, stomach, liver and colorectal cancer was associated with increased participation in LDCT screening. The odds of participants with a family history of one, two, three and four or more cancer cases undergoing LDCT screening were 1.9, 2.7, 2.8 and 3.5 times, respectively, than those without a family history of cancer. Compared to those without a history of cancer, participation in LDCT gradually increased as the number of cancer cases in the family increased (P < .001). Our findings suggest that there is room for improvement in lung cancer screening given the relatively low participation rate. Lung cancer screening in populations with a family history of cancer may improve efficiency and cost‐effectiveness; however, this requires further verification.
format Online
Article
Text
id pubmed-9790604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-97906042022-12-28 Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening Guo, Lan‐Wei Meng, Qing‐Cheng Zheng, Li‐Yang Chen, Qiong Liu, Yin Xu, Hui‐Fang Kang, Rui‐Hua Zhang, Lu‐Yao Liu, Shu‐Zheng Sun, Xi‐Bin Zhang, Shao‐Kai Int J Cancer Cancer Therapy and Prevention We aimed to determine participation in low‐dose computed tomography (LDCT) of individuals with a family history of common cancers in a population‐based screening program to provide timely evidence in high‐risk populations in China. The analysis was conducted using data from the Cancer Screening Program in Urban China (CanSPUC), which recruited 282 377 participants aged 40 to 74 years from eight cities in the Henan province. Using the CanSPUC risk score system, 55 428 participants were evaluated to have high risk for lung cancer and were recommended for LDCT. We calculated the overall and group‐specific participation rates using family history of common cancers and compared differences in participation rates between different groups. Odds ratios (ORs) and 95% confidence intervals were derived by multivariable logistic regression. Of the 55 428 participants, 22 260 underwent LDCT (participation rate, 40.16%). Family history of lung, esophageal, stomach, liver and colorectal cancer was associated with increased participation in LDCT screening. The odds of participants with a family history of one, two, three and four or more cancer cases undergoing LDCT screening were 1.9, 2.7, 2.8 and 3.5 times, respectively, than those without a family history of cancer. Compared to those without a history of cancer, participation in LDCT gradually increased as the number of cancer cases in the family increased (P < .001). Our findings suggest that there is room for improvement in lung cancer screening given the relatively low participation rate. Lung cancer screening in populations with a family history of cancer may improve efficiency and cost‐effectiveness; however, this requires further verification. John Wiley & Sons, Inc. 2022-04-20 2023-01-01 /pmc/articles/PMC9790604/ /pubmed/35362560 http://dx.doi.org/10.1002/ijc.34010 Text en © 2022 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Cancer Therapy and Prevention
Guo, Lan‐Wei
Meng, Qing‐Cheng
Zheng, Li‐Yang
Chen, Qiong
Liu, Yin
Xu, Hui‐Fang
Kang, Rui‐Hua
Zhang, Lu‐Yao
Liu, Shu‐Zheng
Sun, Xi‐Bin
Zhang, Shao‐Kai
Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
title Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
title_full Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
title_fullStr Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
title_full_unstemmed Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
title_short Special issue “The advance of solid tumor research in China”: Participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
title_sort special issue “the advance of solid tumor research in china”: participants with a family history of cancer have a higher participation rate in low‐dose computed tomography for lung cancer screening
topic Cancer Therapy and Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790604/
https://www.ncbi.nlm.nih.gov/pubmed/35362560
http://dx.doi.org/10.1002/ijc.34010
work_keys_str_mv AT guolanwei specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT mengqingcheng specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT zhengliyang specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT chenqiong specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT liuyin specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT xuhuifang specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT kangruihua specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT zhangluyao specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT liushuzheng specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT sunxibin specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening
AT zhangshaokai specialissuetheadvanceofsolidtumorresearchinchinaparticipantswithafamilyhistoryofcancerhaveahigherparticipationrateinlowdosecomputedtomographyforlungcancerscreening